"Determination of Sensitivity and Specificity of Straight Leg Raise Test Via Transforaminal Nerve Root Block
1 other identifier
observational
88
1 country
1
Brief Summary
This study aims to evaluate the diagnostic accuracy of the straight leg raise test in patients with suspected lumbosacral radicular pain. Lumbosacral radicular pain is often caused by lumbar disc herniation and may radiate from the lower back or buttock to the leg. Although the straight leg raise test is commonly used in clinical practice, its diagnostic performance has been reported to vary. In this study, diagnostic transforaminal epidural steroid injection or selective nerve root block will be used as the reference standard. The sensitivity, specificity, likelihood ratios, and area under the curve of the straight leg raise test will be calculated. The findings may help guide clinicians in determining when the straight leg raise test is sufficient and when further diagnostic confirmation may be needed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 11, 2025
CompletedFirst Submitted
Initial submission to the registry
July 6, 2026
CompletedFirst Posted
Study publicly available on registry
July 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 15, 2026
July 10, 2026
July 1, 2026
9 months
July 6, 2026
July 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic Performance of the Straight Leg Raise Test
The diagnostic performance of the straight leg raise test will be evaluated in patients with suspected lumbosacral radicular pain using diagnostic transforaminal epidural steroid injection as the reference standard.
Before and 1 hour after diagnostic transforaminal epidural steroid injection.
Secondary Outcomes (5)
Change in Pain Intensity Assessed by Visual Analog Scale
Before and 1 hour after diagnostic transforaminal epidural steroid injection.
DN-4 Quastionnaire
Before diagnostic transforaminal epidural steroid injection
Intervertebral Disc Degeneration Assessed by Pfirrmann Grading Scale
Using available lumbar magnetic resonance imaging obtained before or after the diagnostic intervention, up to November 1, 2026
Diagnostic Performance of the Bragard Test
Before and 1 hour after diagnostic transforaminal epidural steroid injection
Nerve Root Compression Grade on Lumbar Magnetic Resonance Imaging
Using available lumbar magnetic resonance imaging during the study period, up to November 1, 2026
Study Arms (1)
Patients with Suspected Lumbosacral Radicular Pain
Patients with suspected lumbosacral radicular pain who undergo clinical evaluation including the straight leg raise test and diagnostic transforaminal epidural steroid injection.
Eligibility Criteria
Adult patients aged 18 to 65 years with a preliminary diagnosis of lumbar radicular pain based on medical history, physical examination, and lumbar magnetic resonance imaging, who are scheduled to undergo transforaminal epidural injection targeting the L4, L5, or S1 nerve root, will be included in the study.
You may qualify if:
- Age between 18 and 65 years.
- Preliminary diagnosis of lumbar radicular pain based on medical history, physical examination, and lumbar magnetic resonance imaging.
- Patients scheduled to undergo transforaminal epidural injection targeting the L4, L5, or S1 nerve root.
You may not qualify if:
- Inability to access clinical or procedural records in the hospital system.
- Absence of available radiological records related to the target level, if required.
- Inability to provide reliable NRS or straight leg raise test assessment due to cognitive impairment or language barrier.
- Coagulopathy, defined as INR \> 1.5 or platelet count \< 80,000/mm³, or inability to discontinue anticoagulant or antiplatelet therapy when required.
- Local or systemic infection, or skin lesion at the planned injection site.
- Pregnancy or breastfeeding.
- Known severe hypersensitivity to iodinated contrast material or local anesthetics.
- Progressive neurological deficit or cauda equina syndrome.
- Bilateral or nearly bilateral pain with both sides being prominent and equivalent, or need for therapeutic injection at more than one level during the same session.
- Epidural injection with local anesthetic and/or steroid at the same level within the last 6 weeks.
- Active polyneuropathy or other diffuse neuropathies.
- Active radicular pain originating from nerve roots other than L4, L5, or S1.
- Requirement for mandatory sedation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University Faculty of Medicine, Pendik Training and Research Hospital, Algology Department Recruiting
Istanbul, PENDİK, 34890, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
MİKDAT CAN KARABIYIK
Marmara University Faculty of Medicine ,Marmara University, Department of Physical Medicine and Rehabilitation
- STUDY DIRECTOR
SERDAR KOKAR
Algology Division, Department of Physical Medicine and Rehabilitation, Marmara University Faculty of Medicine
- STUDY DIRECTOR
OSMAN HAKAN GUNDUZ
Algology Division, Department of Physical Medicine and Rehabilitation, Marmara University Faculty of Medicine
- STUDY DIRECTOR
SAVAŞ ŞENCAN
Algology Division, Department of Physical Medicine and Rehabilitation, Marmara University Faculty of Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2026
First Posted
July 10, 2026
Study Start
December 11, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 15, 2026
Last Updated
July 10, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share